Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer.
作者信息
Parker William B
机构信息
Southern Research Institute, 2000 Ninth Avenue, South Birmingham, Alabama 35205, USA.
出版信息
Chem Rev. 2009 Jul;109(7):2880-93. doi: 10.1021/cr900028p.
Abstract
摘要
相似文献
1
Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer.用于癌症治疗的嘌呤和嘧啶抗代谢物的酶学
Chem Rev. 2009 Jul;109(7):2880-93. doi: 10.1021/cr900028p.
2
[The biochemistry of the cancer cell. Purine and pyrimidine metabolism].[癌细胞的生物化学。嘌呤和嘧啶代谢]
Padiatr Padol. 1986;21(4):323-34.
3
Improvement of purine and pyrimidine antimetabolite-based anticancer treatment by selective suppression of mycoplasma-encoded catabolic enzymes.通过选择性抑制支原体编码的分解代谢酶改善基于嘌呤和嘧啶抗代谢物的抗癌治疗。
Lancet Oncol. 2009 Jun;10(6):628-35. doi: 10.1016/S1470-2045(09)70037-3.
4
Novel developments in metabolic disorders of purine and pyrimidine metabolism and therapeutic applications of their analogs.嘌呤和嘧啶代谢紊乱的新进展及其类似物的治疗应用。
Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):165-73. doi: 10.1080/15257770.2014.898071.
5
[Pyrimidine- and purine-type antimetabolites].[嘧啶类和嘌呤类抗代谢物]
Cas Lek Cesk. 1972 Nov 3;111(45):1060-1.
6
Properties of purine and pyrimidine analogs.嘌呤和嘧啶类似物的特性。
Adv Enzyme Regul. 1991;31:433-43. doi: 10.1016/0065-2571(91)90028-k.
7
The design of cancer chemotherapy: metabolic modulation and cellular de novo versus salvage metabolism.癌症化疗的设计：代谢调节与细胞从头合成代谢和补救代谢
Antibiot Chemother (1971). 1980;28:86-93.
8
Modified pyrimidines specifically bind the purine riboswitch.修饰的嘧啶特异性结合嘌呤核糖开关。
J Am Chem Soc. 2006 Nov 8;128(44):14214-5. doi: 10.1021/ja063645t.
9
Purine and pyrimidine metabolism: a firm basis for a transformed society.嘌呤与嘧啶代谢：变革社会的坚实基础。
Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):971-4. doi: 10.1080/15257770600887166.
10
Recent updates on purine and pyrimidine metabolism in physiological and pathological settings.生理和病理环境中嘌呤和嘧啶代谢的最新进展。
Nucleosides Nucleotides Nucleic Acids. 2020;39(10-12):1273-1280. doi: 10.1080/15257770.2020.1730891. Epub 2020 Mar 17.
引用本文的文献
1
Novel purine-linked 1,2,3-triazole derivatives as effective anticancer agents: design, synthesis, docking, DFT, and ADME-T investigations.新型嘌呤连接的1,2,3-三唑衍生物作为有效的抗癌剂：设计、合成、对接、密度泛函理论及药物代谢动力学-药物毒性学研究
Sci Rep. 2025 Jul 23;15(1):26853. doi: 10.1038/s41598-025-95669-5.
2
Hybrid Molecules with Purine and Pyrimidine Derivatives for Antitumor Therapy: News, Perspectives, and Future Directions.用于抗肿瘤治疗的含嘌呤和嘧啶衍生物的杂合分子：新进展、前景与未来方向
Molecules. 2025 Jun 23;30(13):2707. doi: 10.3390/molecules30132707.
3
From molecule to medicine: introducing emerging strategies to synthesize potent anticancer purine scaffolds.从分子到药物：介绍合成强效抗癌嘌呤支架的新兴策略。
RSC Adv. 2025 Jun 25;15(27):21604-21638. doi: 10.1039/d5ra02893k. eCollection 2025 Jun 23.
4
Synthesis of Purine-1,4,7,10-Tetraazacyclododecane Conjugate and Its Complexation Modes with Copper(II).嘌呤-1,4,7,10-四氮杂环十二烷共轭物的合成及其与铜（II）的络合模式
Molecules. 2025 Apr 4;30(7):1612. doi: 10.3390/molecules30071612.
5
Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy.传统抗癌疗法的进展与局限：手术、化疗、放疗及激素疗法的全面综述
Discov Oncol. 2025 Apr 24;16(1):607. doi: 10.1007/s12672-025-02198-8.
6
Glucose- and glutamine-driven de novo nucleotide synthesis facilitates WSSV replication in shrimp.葡萄糖和谷氨酰胺驱动的从头核苷酸合成促进对虾中白斑综合征病毒的复制。
Cell Commun Signal. 2025 Apr 22;23(1):191. doi: 10.1186/s12964-025-02186-z.
7
Nucleotide metabolism-associated drug resistance gene NDUFA4L2 promotes colon cancer progression and 5-FU resistance.核苷酸代谢相关耐药基因NDUFA4L2促进结肠癌进展及5-氟尿嘧啶耐药。
Sci Rep. 2025 Jan 2;15(1):570. doi: 10.1038/s41598-024-84353-9.
8
Systemic inhibition of purine biosynthesis prevents weight gain and improves metabolic health by increasing thermogenesis and decreasing food intake.嘌呤生物合成的全身抑制通过增加产热和减少食物摄入量来防止体重增加并改善代谢健康。
bioRxiv. 2024 Nov 1:2024.10.28.620705. doi: 10.1101/2024.10.28.620705.
9
Precious Cargo: The Role of Polymeric Nanoparticles in the Delivery of Covalent Drugs.珍贵货物：聚合物纳米粒子在共价药物传递中的作用。
Molecules. 2024 Oct 19;29(20):4949. doi: 10.3390/molecules29204949.
10
Azole Combinations and Multi-Targeting Drugs That Synergistically Inhibit .协同抑制的唑类组合药物和多靶点药物
J Fungi (Basel). 2024 Oct 7;10(10):698. doi: 10.3390/jof10100698.
本文引用的文献
1
p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia.p53诱导的核糖核苷酸还原酶（p53R2/RRM2B）是一种与DNA低甲基化无关的地西他滨基因靶点，其与骨髓增生异常综合征/急性髓系白血病的临床反应相关。
Cancer Res. 2008 Nov 15;68(22):9358-66. doi: 10.1158/0008-5472.CAN-08-1860.
2
Prodrug cancer gene therapy.前体药物癌症基因治疗。
Cancer Lett. 2008 Nov 8;270(2):191-201. doi: 10.1016/j.canlet.2008.04.023. Epub 2008 May 27.
3
Repair of 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine-induced DNA single-strand breaks by transcription-coupled nucleotide excision repair.通过转录偶联核苷酸切除修复对2'-C-氰基-2'-脱氧-1-β-D-阿拉伯呋喃糖基胞嘧啶诱导的DNA单链断裂的修复
Cancer Res. 2008 May 15;68(10):3881-9. doi: 10.1158/0008-5472.CAN-07-6885.
4
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine.DNA甲基转移酶抑制剂阿扎胞苷和地西他滨的作用模式。
Int J Cancer. 2008 Jul 1;123(1):8-13. doi: 10.1002/ijc.23607.
5
Pharmacology and mechanism of action of forodesine, a T-cell targeted agent.福多司坦，一种T细胞靶向药物的药理学及作用机制
Semin Oncol. 2007 Dec;34(6 Suppl 5):S8-12. doi: 10.1053/j.seminoncol.2007.11.003.
6
Forodesine treatment and post-transplant graft-versus-host disease in two patients with acute leukemia: facilitation of graft-versus-leukemia effect?两名急性白血病患者接受福多司坦治疗及移植后移植物抗宿主病：是否促进了移植物抗白血病效应？
Semin Oncol. 2007 Dec;34(6 Suppl 5):S35-9. doi: 10.1053/j.seminoncol.2007.11.005.
7
Purine nucleoside phosphorylase inhibition as a novel therapeutic approach for B-cell lymphoid malignancies.抑制嘌呤核苷磷酸化酶作为B细胞淋巴恶性肿瘤的一种新型治疗方法。
Semin Oncol. 2007 Dec;34(6 Suppl 5):S29-34. doi: 10.1053/j.seminoncol.2007.11.004.
8
Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine.三种治疗急性淋巴细胞白血病的新药：奈拉滨、氯法拉滨和福达华。
Semin Oncol. 2007 Dec;34(6 Suppl 5):S13-20. doi: 10.1053/j.seminoncol.2007.11.002.
9
Nelarabine: a novel purine antimetabolite antineoplastic agent.奈拉滨：一种新型嘌呤抗代谢抗肿瘤药。
Clin Ther. 2007 Sep;29(9):1887-99. doi: 10.1016/j.clinthera.2007.09.002.
10
Troxacitabine in acute leukemia.曲沙他滨治疗急性白血病
Hematology. 2007 Jun;12(3):219-27. doi: 10.1080/10245330701406881.
Zotero 插件